The week in health tech, explained in plain English.Get the free newsletter →
October 8, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Government

Ebola Still Kills in DRC as Health Groups Fight to Save Lives

Ebola remains a lethal threat in Central Africa, where the Democratic Republic of Congo has faced what KFF Health News calls the second-deadliest outbreak on record. The virus keeps resurfacing, and the response depends on health workers who continue treating patients and training local caregivers even as attention and resources shift elsewhere.

In practice, that means sustaining the unglamorous infrastructure of outbreak control: case identification, safe treatment, and hands-on instruction for the caregivers closest to patients. According to KFF Health News, these groups are doing that work on the ground in the DRC, where insecurity, weak health systems, and recurring flare-ups make containment difficult and expensive.

For healthcare leaders and funders, the DRC is a reminder that Ebola is not a solved problem. Progress hinges on steady financing, trained personnel, and durable local capacity rather than one-time emergency surges. When that support wavers, the gaps show up quickly in lives lost.

More in Government

Government

White House Plans $100M STEM PhD Push as NIH Sheds Scientists

The Trump administration plans to put over $100 million into STEM PhD fellowships, announced at an Oct. 8 White House summit, even as the NIH loses scientists.

Why it matters: The PhD pipeline fuels biomedical research across hospitals and biotech, but new fellowship funding may not offset talent losses at the NIH.

Government

Stem Cell Advocates Eye FDA Opening Under RFK Jr.

Stem cell advocates hope the FDA will grant their unproven therapies legitimacy under RFK Jr., mirroring how peptides gained acceptance through the MAHA movement.

Why it matters: If regulatory politics rather than clinical evidence starts shaping FDA acceptance, it could reshape patient access and safety standards across emerging therapies.

Government

Ashish Jha Warns AI Is Lowering the Bar for Bioweapons

Ashish Jha warns in STAT News that AI is eroding the barriers that kept biological weapons rare, and defenses will take years the world cannot spare.

Why it matters: If AI makes bioweapons easier to build faster than defenses can be developed, the risk to public health and national security grows sharply.